#1
#1 out of 1
health10h ago
Key facts: Wegovy UK OK; US oral GLP‑1; amycretin; pricing; Hims deal
- UK approves Wegovy for adults with prior heart disease and BMI 27+, expanding access to about 1.2 million people.
- In the US, Novo Nordisk won FDA approval and launched the first oral GLP-1 pill for obesity.
- US self-pay price for Wegovy oral starts at $149 per month; injectables priced higher.
- Novo Nordisk reported amycretin mid-stage results showing up to 14.5% weight loss at 36 weeks.
- Hims & Hers resolved a dispute over compounded Wegovy versions, with potential supply impacts.
Vote 0